Piper Sandler Reiterates Overweight Rating on Colgate-Palmolive Amid Tariff Strategy

Piper Sandler reiterated its $109 price target and Overweight rating on Colgate-Palmolive Company (NYSE:CL) on May 28. The update follows insights into Colgate’s success and future prospects, which were shared during a recent meeting with John Faucher, Chief Investor Relations Officer, and Noel Wallace, the company’s CEO.

Colgate-Palmolive Company (NYSE:CL) appears to be managing the current tariff situation effectively, which was the main topic of discussion throughout the conference. The emphasis is now on the company’s performance in various geographical areas, as well as the possibility of both favorable developments and difficulties that may affect the company’s guidance.

As it continues to manage tariff effects predicted to increase expenses by $200 million for the year, Colgate-Palmolive Company (NYSE:CL) plans to exit the private label sector by the third quarter of 2025. The company also disclosed continued investments in product development and supply chain management.

While we acknowledge the potential of CL to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CL and that has 100x upside potential, check out our report about the cheapest AI stock.

Read More: 10 Defensive Stocks Billionaire Ken Fisher Is Betting On and 10 Best Stocks to Buy According to Billionaire Steve Cohen.

Disclosure: None.